InflammX Therapeutics, Inc. — Form D
InflammX Therapeutics, Inc. of TAMPA, FL, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-19. The offering totals $8.4M, of which $8.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-11-19
- Form: D
- Accession: 0001840051-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $8.4M
- Amount sold: $8.4M
- Investors: 6
- Date of first sale: 2021-11-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-421863
Issuer
- Name: InflammX Therapeutics, Inc.
- CIK: 0001840051
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 275 BAYSHORE BLVD, UNIT 1607, TAMPA, FL, 33606
- Phone: 858-480-2404
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Jason Werner | Director | Walpole, MA |
| James Blair | Director | San Diego, CA |
| David Pool | Executive Officer | San Diego, CA |
| Brian Levy | Director | Syosset, NY |
| Brian Levy | Executive Officer | Syosset, NY |
| Rajiv Shukla | Director | Pittsburgh, PA |
| Richard Rubino | Director | Boston, MA |
| Phil Rosenfeld | Director | Tampa, FL |
| David Boyer | Director | Tampa, FL |
Other filings by this issuer (2)
More